Log in to save to my catalogue

Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSC...

Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSC...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1926978803

Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC

About this item

Full title

Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC

Publisher

Netherlands: Elsevier B.V

Journal title

Clinical neurology and neurosurgery, 2017-09, Vol.160, p.96-100

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier B.V

More information

Scope and Contents

Contents

Highlights•EGFR mutation is associated with higher incidence of brain metastases for patients with advanced non-squamous NSCLC. •The use of a TKI is associated with higher incidence of brain metastases for patients with advanced non-squamous NSCLC. •For patients with brain metastases, the survival was significantly longer in EGFR+ patients than in...

Alternative Titles

Full title

Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1926978803

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1926978803

Other Identifiers

ISSN

0303-8467

E-ISSN

1872-6968

DOI

10.1016/j.clineuro.2017.06.022

How to access this item